EMEA-002204-PIP02-20 - paediatric investigation plan

branaplam

Key facts

• Active substance:
  branaplam
• Therapeutic area:
  Neurology
• Decision number:
  P/0449/2022
• PIP number:
  EMEA-002204-PIP02-20
• Pharmaceutical form(s):
  Oral solution
• Condition(s) / indication(s):
  Treatment of Huntington's disease
• Route(s) of administration:
  Oral use
• Decision type:
  P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
• Decision date:
  28/10/2022
• Compliance check done:
  No

Decision

P/0449/2022 : EMA decision of 28 October 2022 on the agreement of a paediatric investigation plan and on the granting of a waiver for branaplam (EMEA-002204-PIP02-20)

Reference Number: EMA/834865/2022